GNRH1 and cancer: In particular, the detailed mapping of GnRH1R activation pathways and membrane-mediated modulation offers a structural framework for rational design of GnRH analogues and antagonists, enabling optimisation of ligand-receptor interactions to enhance therapeutic efficacy and selectivity in reproductive hormone-dependent disorders and related cancers.